Leading Immunotherapy Researcher Norman M. Greenberg Is Atreca’s New Chief Scientific Officer
News
Privately-held biotech Atreca Inc., dedicated to the development of novel therapeutics based on human immune responses, has announced the appointment of a new Chief Scientific Officer (CSO), Norman M. Greenberg, Ph.D. ... Read more